Senthilkumaran, S., Sampath, S., Miller, S. W., Almeida, J. R., Williams, J., Williams, H. F., Thirumalaikolundusubramanian, P., Patel, K. and Vaiyapuri, S.
ORCID: https://orcid.org/0000-0002-6006-6517
(2023)
Partial segmental thrombosis of the corpus cavernosum following Russell’s viper bite.
Toxicon, 234.
107284.
ISSN 0041-0101
doi: 10.1016/j.toxicon.2023.107284
Abstract/Summary
Snakebite envenoming (SBE) is common in rural communities living in tropical regions that often have fragile and/or overwhelmed healthcare systems. The complex scenarios around SBE lead to a high number of deaths, disabilities, and long-term consequences in patients. Russell’s viper (Daboia russelii) is one of the most medically important snake species in India, which causes devastating pathological conditions characterised by a wide range of clinical manifestations. This broad spectrum of symptoms requires additional therapeutic interventions beyond the classical antivenom administration. Hence, positive outcomes for patients affected by SBE can be achieved with a better understanding of previous experiences describing clinical manifestations and various therapeutic interventions including for rare and underreported conditions. Here, we report an SBE victim who developed partial segmental thrombosis in the corpus cavernosum following Russell’s viper envenomation and its diagnostic and treatment approaches. The patients received 180 ml of antivenom to resolve the abnormalities in their haematological parameters. Despite antivenom treatment, they developed severe pain in their genital region, and subsequent ultrasound and magnetic resonance imaging confirmed segmental thrombosis in the corpus cavernosum, which required supportive measures. The treatment using low molecular weight heparin, rivaroxaban and non-steroidal anti-inflammatory drugs resolved segmental thrombosis. In conclusion, this case report exemplifies the development of a rare segmental thrombosis in corpus cavernosum and how the medical, scientific, and general community can benefit from documenting clinical manifestations, medically relevant insights into patient care and the management of underreported complications.
Altmetric Badge
| Item Type | Article |
| URI | https://reading-clone.eprints-hosting.org/id/eprint/113193 |
| Identification Number/DOI | 10.1016/j.toxicon.2023.107284 |
| Refereed | Yes |
| Divisions | Life Sciences > School of Biological Sciences > Biomedical Sciences Life Sciences > School of Chemistry, Food and Pharmacy > School of Pharmacy > Division of Pharmacology |
| Publisher | Elsevier |
| Download/View statistics | View download statistics for this item |
Downloads
Downloads per month over past year
University Staff: Request a correction | Centaur Editors: Update this record
Download
Download